Source: Haematologica. Conference titles: Congress of The European Hematology Association. Unidade: FMRP
Assunto: ANEMIA FALCIFORME (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA PINTO, A. C. et al. Hidroxiyurea treatment of sickle cell diseases causes megaloblastic transformation of the bone marrow that is responsible for the increase of the mean corpuscular volume. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2007APA
Silva Pinto, A. C., Carrara, R. C., Oliveira, V. C., Palma, P. V., Campos, A. D., Zago, M. A., & Covas, D. T. (2007). Hidroxiyurea treatment of sickle cell diseases causes megaloblastic transformation of the bone marrow that is responsible for the increase of the mean corpuscular volume. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Silva Pinto AC, Carrara RC, Oliveira VC, Palma PV, Campos AD, Zago MA, Covas DT. Hidroxiyurea treatment of sickle cell diseases causes megaloblastic transformation of the bone marrow that is responsible for the increase of the mean corpuscular volume. Haematologica. 2007 ; 92 298.[citado 2024 nov. 02 ]Vancouver
Silva Pinto AC, Carrara RC, Oliveira VC, Palma PV, Campos AD, Zago MA, Covas DT. Hidroxiyurea treatment of sickle cell diseases causes megaloblastic transformation of the bone marrow that is responsible for the increase of the mean corpuscular volume. Haematologica. 2007 ; 92 298.[citado 2024 nov. 02 ]
